Spectroscopic analysis of metabolic profile in patients with relapsed multiple sclerosis
Open Access
- 23 December 2022
- journal article
- research article
- Published by ECO-Vector LLC in Annals of Clinical and Experimental Neurology
- Vol. 16 (4) , 12-17
Abstract
Introduction. Managing patients with relapsing-remitting multiple sclerosis (RMS) remains a pressing issue. Objective. To detect the reversible metabolic changes of the brain matter in patients with clinically exacerbated RMS and to follow them up after intravenous glucocorticoid (IVGC) treatment. Materials and methods. Neurological examination and neuroimaging in the RMS patients included expanded disability status scale (EDSS) scoring, conventional brain magnetic resonance imaging (MRI), and proton nuclear magnetic resonance spectroscopy (1H-NMR spectroscopy) before and after IVGC treatment. Multivoxel 1H-NMR spectroscopy was used to assess metabolism in the centra semiovale and cingulate gyri. Results. Based on the multivoxel 1H-NMR spectroscopy, relative metabolite concentrations in the grey and white matter statistically differed within the study cohort before and after the IVGC treatment. The N-acetylaspartate/choline ratio significantly recovered and the choline/creatine ratio decreased in the anterior cingulate gyri in 27% of patients. The brainstem function score significantly improved in the metabolic response group as compared to the non-metabolic response group. Conclusion. We should study the potential predictors of RMS activity and the IVGC response to select the RMS relapses when pulse-therapy with IVGCs is definitely indicated. Spectroscopy may reveal RMS pathogenesis variability earlier than conventional MRI.Keywords
This publication has 24 references indexed in Scilit:
- Magnetic resonance monitoring of lesion evolution in multiple sclerosisTherapeutic Advances in Neurological Disorders, 2013
- Clinical prognostic factors in multiple sclerosis: a natural history reviewNature Reviews Neurology, 2009
- Proton Magnetic Resonance Spectroscopy in Multiple SclerosisNeuroimaging Clinics Of North America, 2009
- Guidelines for using proton MR spectroscopy in multicenter clinical MS studiesNeurology, 2007
- Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance SpectroscopyAmerican Journal of Neuroradiology, 2007
- Magnetic Resonance Spectroscopy in the Monitoring of Multiple SclerosisJournal of Neuroimaging, 2005
- Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosisBrain, 2002
- Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosisAnnals of Neurology, 1998
- Chemical pathology of acute demyelinating lesions and its correlation with disabilityAnnals of Neurology, 1995
- The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratioMagnetic Resonance in Medicine, 1993